Entera Bio Financials - Benzinga

Entera Bio Ltd

ENTXNASDAQ

Trade with Public

Trade with Public

$3.03

-0.05-1.62%

At close: Aug 28, 5:00 PM EST

$3.03

N/A

After Hours: Aug 28, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Entera Bio Financials

Entera Bio (ENTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Entera Bio Q2 EPS $(0.14) Misses $(0.08) Estimate

Benzinga Newsdesk

PRO
Entera Bio Q1 EPS $(0.07) Beats $(0.08) Estimate

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 16.67 percent decrease over losses of $(0.06) per share from the

Benzinga Newsdesk

Stock Market Today: S&P 500, Dow, Nasdaq Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'— PLTR, RZLV, ENTX In Focus (UPDATED)

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the story. U.S. stock futures rose on Monday following Friday’s sharp sell-off. Futures of the major benchmark indices were higher after they entered the correction territory last week, falling more than 10% below their 52-week highs.

Rishabh Mishra

Phreesia, Progress Software And 3 Stocks To Watch Heading Into Monday

U.S. stock futures up, focus on quarterly earnings of Americas Gold and Silver, ARKO Petroleum, Entera Bio, Phreesia, and Progress Software.

Avi Kapoor

PRO
Entera Bio Q4 EPS $(0.06) Beats $(0.09) Estimate

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

PRO
Entera Bio Q3 EPS $(0.07) Beats $(0.09) Estimate

Benzinga Newsdesk